Skip to content
healthcare.dev

TOUJEO Max

NDC 50090-4177, insulin glargine, injection, solution, from A-S Medication Solutions.

Product NDC
50090-4177
Status
Listed
Labeler
A-S Medication Solutions
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA206538
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50090-4177 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN GLARGINE300 U/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
50090-4177-0500904177002 SYRINGE in 1 CARTON (50090-4177-0) / 3 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/620b9a3d-8d8c-4c0a-b5a2-f269d6cc9ab9

Use it

Look up 50090-4177 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50090-4177 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50090-4177. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.